Total Payments
$3,448
2024 Payments
$563.96
Companies
36
Transactions
185
Medicare Patients
11,277
Medicare Billing
$996,726
Payment Breakdown by Category
Food & Beverage$3,383 (98.1%)
Education$65.00 (1.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,383 | 184 | 98.1% |
| Education | $65.00 | 1 | 1.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $624.81 | 39 | $0 (2024) |
| Dendreon Pharmaceuticals LLC | $344.82 | 14 | $0 (2024) |
| Astellas Pharma US Inc | $279.19 | 18 | $0 (2024) |
| Endo Pharmaceuticals Inc. | $173.98 | 11 | $0 (2024) |
| Boston Scientific Corporation | $165.24 | 7 | $0 (2024) |
| UROGEN PHARMA, INC. | $158.32 | 7 | $0 (2024) |
| AbbVie Inc. | $142.09 | 10 | $0 (2023) |
| 180 Medical, Inc. | $136.85 | 6 | $0 (2024) |
| Medtronic, Inc. | $118.06 | 5 | $0 (2024) |
| PFIZER INC. | $111.92 | 6 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $563.96 | 26 | UROGEN PHARMA, INC. ($90.47) |
| 2023 | $741.26 | 36 | Janssen Biotech, Inc. ($173.90) |
| 2022 | $495.26 | 27 | Janssen Biotech, Inc. ($57.28) |
| 2021 | $158.74 | 10 | Medtronic, Inc. ($31.49) |
| 2020 | $220.67 | 14 | Astellas Pharma US Inc ($51.01) |
| 2019 | $590.22 | 33 | Janssen Biotech, Inc. ($133.68) |
| 2018 | $491.74 | 31 | Janssen Biotech, Inc. ($171.06) |
| 2017 | $185.71 | 8 | Endocare, Inc. ($60.30) |
All Payment Transactions
185 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $26.96 | General |
| Category: Oncology | ||||||
| 12/09/2024 | Ambu Inc. | — | Food and Beverage | Cash or cash equivalent | $18.18 | General |
| 11/20/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: UROTHELIAL CANCER | ||||||
| 10/29/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA, BALVERSA | Food and Beverage | In-kind items and services | $21.30 | General |
| Category: Oncology | ||||||
| 10/24/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $22.63 | General |
| Category: Oncology | ||||||
| 10/10/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $24.55 | General |
| Category: UROTHELIAL CANCER | ||||||
| 09/23/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: Oncology | ||||||
| 09/19/2024 | Becton, Dickinson and Company | Bard Urinary Drainage Bag (Device) | Food and Beverage | In-kind items and services | $40.89 | General |
| Category: Urology | ||||||
| 09/18/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: UROLOGY | ||||||
| 09/09/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $20.95 | General |
| Category: UROTHELIAL CANCER | ||||||
| 08/29/2024 | Medtronic, Inc. | APS (Device) | Food and Beverage | In-kind items and services | $39.14 | General |
| Category: Nerve Monitoring Products | ||||||
| 08/29/2024 | Ambu Inc. | — | Food and Beverage | Cash or cash equivalent | $17.00 | General |
| 07/31/2024 | Ambu Inc. | — | Food and Beverage | Cash or cash equivalent | $3.76 | General |
| 07/18/2024 | Ambu Inc. | — | Food and Beverage | Cash or cash equivalent | $17.45 | General |
| 06/27/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA, BALVERSA | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: Oncology | ||||||
| 06/12/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $21.91 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 06/07/2024 | Axonics, Inc. | Bulkamid (Device) | Food and Beverage | In-kind items and services | $24.30 | General |
| Category: Urology | ||||||
| 03/25/2024 | Endo Pharmaceuticals Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $21.21 | General |
| Category: UROLOGY | ||||||
| 03/19/2024 | Ambu Inc. | — | Food and Beverage | Cash or cash equivalent | $13.62 | General |
| 03/14/2024 | Boston Scientific Corporation | Upsylon (Device) | Food and Beverage | In-kind items and services | $32.16 | General |
| Category: Upsylon_URO | ||||||
| 03/06/2024 | 180 Medical, Inc. | CURE CATHETER (Device) | Food and Beverage | In-kind items and services | $24.74 | General |
| Category: CONTINENCE CARE | ||||||
| 02/21/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: Oncology | ||||||
| 02/15/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $20.61 | General |
| Category: Oncology | ||||||
| 02/07/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $23.51 | General |
| Category: UROTHELIAL CANCER | ||||||
| 02/05/2024 | Olympus America Inc. | iTIND System (Device) | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: Urology Gynecology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 29 | 3,047 | 3,921 | $1.3M | $254,065 |
| 2022 | 27 | 2,709 | 3,534 | $1.3M | $223,748 |
| 2021 | 30 | 2,858 | 3,715 | $1.5M | $259,579 |
| 2020 | 29 | 2,663 | 3,644 | $1.4M | $259,334 |
Total Patients
11,277
Total Services
14,814
Medicare Billing
$996,726
Procedure Codes
121
All Medicare Procedures & Services
121 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 663 | 828 | $117,699 | $48,778 | 41.4% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 47 | 362 | $242,791 | $48,027 | 19.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 405 | 508 | $120,843 | $42,765 | 35.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 164 | 164 | $52,122 | $18,320 | 35.1% |
| 50590 | Shock wave crushing of kidney stones | Facility | 2023 | 36 | 41 | $120,097 | $17,135 | 14.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 146 | 146 | $31,762 | $10,935 | 34.4% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 142 | 176 | $80,850 | $9,545 | 11.8% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 37 | 46 | $91,399 | $7,542 | 8.3% |
| 52601 | Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | Facility | 2023 | 13 | 13 | $33,572 | $6,823 | 20.3% |
| 52287 | Exam with injections of chemical for destruction of bladder using an endoscope | Facility | 2023 | 40 | 51 | $45,554 | $5,676 | 12.5% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 58 | 58 | $27,504 | $5,189 | 18.9% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 485 | 566 | $23,416 | $4,202 | 17.9% |
| 52234 | Destruction and/or removal of growth of bladder and urethra using an endoscope, 0.5-2.0 cm | Facility | 2023 | 16 | 19 | $16,160 | $3,379 | 20.9% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 23 | 30 | $29,514 | $2,940 | 10.0% |
| 51728 | Complex measurement of pressure of urine flow in bladder with voiding pressure studies | Office | 2023 | 12 | 12 | $10,400 | $2,690 | 25.9% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Facility | 2023 | 22 | 22 | $16,238 | $2,237 | 13.8% |
| 51741 | Electronic assessment of bladder emptying | Office | 2023 | 177 | 193 | $31,518 | $1,768 | 5.6% |
| 52441 | Insertion of implant in urethra within prostate gland using an endoscope, 1 implant | Facility | 2023 | 11 | 11 | $41,383 | $1,636 | 4.0% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 47 | 62 | $5,928 | $1,420 | 24.0% |
| 51700 | Simple bladder irrigation and/or instillation | Office | 2023 | 18 | 25 | $4,319 | $1,393 | 32.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 125 | 166 | $3,652 | $1,387 | 38.0% |
| 51797 | Insertion of device into abdomen with pressure and urine flow rate study | Office | 2023 | 12 | 12 | $4,899 | $1,383 | 28.2% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 14 | 28 | $5,317 | $1,250 | 23.5% |
| 52442 | Insertion of implant in urethra within prostate gland using an endoscope, each additional implant | Facility | 2023 | 11 | 33 | $77,250 | $1,245 | 1.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 16 | 16 | $4,149 | $1,189 | 28.7% |
About Dr. Brian Smith, MD
Dr. Brian Smith, MD is a Urology healthcare provider based in Salina, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/05/2005. The National Provider Identifier (NPI) number assigned to this provider is 1952385817.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Smith, MD has received a total of $3,448 in payments from pharmaceutical and medical device companies, with $563.96 received in 2024. These payments were reported across 185 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($3,383).
As a Medicare-enrolled provider, Smith has provided services to 11,277 Medicare beneficiaries, totaling 14,814 services with total Medicare billing of $996,726. Data is available for 4 years (2020–2023), covering 121 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Salina, KS
- Active Since 12/05/2005
- Last Updated 01/06/2023
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1952385817
Products in Payments
- Erleada (Drug) $369.55
- PROVENGE (Drug) $365.68
- ERLEADA (Drug) $315.23
- XTANDI (Drug) $250.73
- XIAFLEX (Biological) $171.68
- JELMYTO (Drug) $158.32
- Noctiva (Drug) $111.64
- BOTOX (Biological) $106.92
- Xtandi (Drug) $90.91
- LUPRON DEPOT (Drug) $86.48
- UroLift (Device) $84.35
- APS (Device) $72.24
- 1588 HD 3 CHIP CAMERA (Device) $66.97
- Endocare Cryocare System (Medical Supply) $60.30
- Bulkamid (Device) $51.50
- iTIND System (Device) $50.07
- PYLARIFY (Drug) $49.18
- INTERSTIM (Device) $45.82
- AQUABEAM ROBOTIC SYSTEM (Device) $44.96
- CURE CATHETER (Device) $42.94
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Salina
Dr. Ryan Payne, M.d, M.D
Urology — Payments: $13,580
Urology $13,580
Dr. Michael Matteucci, M.d, M.D
Urology — Payments: $3,228
Urology $3,228
William Mauch, Md, MD
Urology — Payments: $2,219
Urology $2,219
Randy Hassler, Md, MD
Urology — Payments: $593.70
Urology $593.70
Donald Shrader, Md, MD
Urology
Urology